DNAPrint Genomics, Inc.
DNAPrint Genomics updates first quarter business activity
Published in Genetics and Environmental Business Week, June 29th, 2006
"Our DNAPrint Pharmaceuticals, Inc. subsidiary continued to move forward with the development of PT-401, a 'Super EPO' (erythropoietin) dimer protein drug for treatment of anemia in renal dialysis patients, the company's first drug, and we experienced a considerable revenue increase in our genotyping services and legacy ancestry business with our A NCESTRYbyDNA product," Gabriel stated.
Revenues in the first quarter of 2006...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- AstraZeneca
AstraZeneca invests $100M in China research and development - Corautus Genetics Inc.
Corautus Genetics receives NASDAQ deficiency notice related to minimum bid price - University Hospitals of Cleveland
University Hospitals of Cleveland receives $250,000 grant for breast cancer research - Addenbrooke's Hospital, Cambridge, England
Researchers' findings from the United Kingdom, Germany and South Korea advance genetics research - Alberta Children's Hospital
Dilated cardiomyopathy with ataxia syndrome is caused by mutation of DNAJC19 - American Association for the Study of Liver Diseases
Education and guidelines needed for genetic testing in liver disease - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
